Institut Català de la Salut
[García-Estévez L] Breast Cancer Department, MD Anderson Cancer Center, Madrid, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [Cortés J] International Breast Cancer Center (IBCC), Barcelona, Spain. Medical Scientia Innovation Research (MedSIR), Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Pérez S, Calvo I, Gallegos I] Breast Cancer Department, MD Anderson Cancer Center, Madrid, Spain. [Moreno-Bueno G] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas ‘Alberto Sols’ (CSIC-UAM), IdiPaz, & Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. MD Anderson International Foundation, Madrid, Spain
Vall d'Hebron Barcelona Hospital Campus
2022-02-01T13:41:23Z
2022-02-01T13:41:23Z
2021-08-13
Mamografia; Menopausa; Obesitat
Mamografía; Menopausia; Obesidad
Mammogram; Menopause; Obesity
Breast cancer is the most common tumor in women worldwide, and an increasing public health concern. Knowledge of both protective and negative risk factors is essential for a better understanding of this heterogenous disease. We undertook a review of the recent literature and evaluated the relationship between obesity mediators and breast cancer development depending on menopausal status. Excess weight is now pandemic and has replaced tobacco as the main lifestyle-related risk factor for premature death. Although the prevalence of obesity/overweight has increased globally over the last 50 years, the potential harm attributable to excess fat has generally been underestimated. The relationship between overweight/obesity, breast cancer and overall risk appears to be highly dependent on menopausal status. Thus, obesity increases the risk of breast cancer in postmenopausal women but, conversely, it appears to be protective in premenopausal women. We evaluate the role of different clinical factors potentially involved in this seemingly contradictory relationship, including estrogen, mammogram density, adipokines, insulin-signaling pathway activation, and inflammatory status. A key focus of this review is to better understand the impact of body mass index and menopausal status on these clinical factors and, hence, provide some clarity into the inter-relationships involved in this controversial issue.
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Article
Published version
English
Mama - Càncer; Obesitat - Complicacions; Menopausa; DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms; DISEASES::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity; Other subheadings::Other subheadings::Other subheadings::/complications; PHENOMENA AND PROCESSES::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Climacteric::Menopause; ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama; ENFERMEDADES::enfermedades nutricionales y metabólicas::trastornos nutricionales::hipernutrición::obesidad; Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones; FENÓMENOS Y PROCESOS::fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::climaterio::menopausia
Frontiers Media
Frontiers in Oncology;11
https://doi.org/10.3389/fonc.2021.705911
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/